Catalyxx: Funding, Investors & Team (Oct 2026)
Catalyxx is an innovative company in the green technology sector that is revolutionizing the chemical industry by replacing fossil-based feedstocks. Their patented catalytic chemistry technology converts bioethanol into valuable intermediate chemicals, such as butanol, hexanol, octanol, and decanol. The proven technology, demonstrated at a Demo Plant, is scalable and ready for industrial deployment. Additionally, it is carbon negative, reducing 3.5kg of CO2 for every kg of chemical produced. Catalyxx aims to become a global leader in catalytic chemistry, enabling the substitution of petrochemical products derived from crude oil with those made from sustainable and bio-based sources.
Catalyxx has raised $9.1M across 2 funding rounds on record, the most recent an undisclosed round of $3.4M announced in May 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Catalyxx Company Profile and Key Stats
Latest funding round on record: May 2025.
Catalyxx Funding Rounds
Catalyxx raised $5.7M in a Series A announced in Nov 2024.
6 months later, an undisclosed round of $3.4M was announced in May 2025.
Catalyxx Founders and Leadership Team
Contact details for the Catalyxx team: 1 of 1 has an email address on file.
Start 14-day free trial →Catalyxx Funding Compared to Other Biotechnology Startups
Catalyxx's latest round of $3.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Catalyxx in Biotechnology and Chesterfield
Companies Similar to Catalyxx
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Catalyxx Funding FAQs
What does Catalyxx do?
Catalyxx is an innovative company in the green technology sector that is revolutionizing the chemical industry by replacing fossil-based feedstocks. Their patented catalytic chemistry technology converts bioethanol into valuable intermediate chemicals, such as butanol, hexanol, octanol, and decanol. The proven technology, demonstrated at a Demo Plant, is scalable and ready for industrial deployment. Additionally, it is carbon negative, reducing 3.5kg of CO2 for every kg of chemical produced. Catalyxx aims to become a global leader in catalytic chemistry, enabling the substitution of petrochemical products derived from crude oil with those made from sustainable and bio-based sources.
How much funding has Catalyxx raised?
Catalyxx has raised $9.1M across 2 rounds on record. The most recent is an undisclosed round of $3.4M announced in May 2025.
When did Catalyxx last raise funding?
Catalyxx's most recent funding round on record is an undisclosed round of $3.4M, announced in May 2025.
Who founded Catalyxx?
FundedIQ lists Joaquin Alarcon De La Lastra Romero (Founder) at Catalyxx.
Where is Catalyxx headquartered?
Catalyxx is based in Chesterfield, Missouri, United States.
How many employees does Catalyxx have?
Catalyxx is in the 11-50 employee band.
How does Catalyxx's funding compare to other Biotechnology startups?
Catalyxx's latest round of $3.4M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Catalyxx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Catalyxx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.